Trial
NCT00293150
Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Cleveland Clinic
Collaborators
—
Condition
Diastolic Heart Failure
Intervention
Eplerenone
Why stopped
Lack of eligible patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-27